Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 7, 2012
Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens
Patrick J Stiff, Mary P Fox-Geiman, Karen Kiley, et al.
American Journal of Hematology
|
August 3, 2013
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34(+) hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma
Ivana N Micallef, Patrick J Stiff, Edward A Stadtmauer, et al.
Transplantation and Cellular Therapy
|
April 20, 2026
QTc Prolongation in Allogeneic Hematopoietic Stem Cell Transplantation: Assessing Cardiac Complications and Survival Outcomes
Mark F deBettencourt, Timothy E O'Connor, Kayeromi Gomez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2002
Autologous stem cell transplantation for small cell lung cancer
J Douglas Rizzo, Anthony D Elias, Patrick J Stiff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 4, 2010
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma
Patrick J Stiff, Ivana Micallef, Auayporn P Nademanee, et al.
Transplantation and Cellular Therapy
|
April 9, 2025
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
Mitchell E Horwitz, Gary J Schiller, Stephanie B Tsai, et al.
Blood
|
February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)
John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Cancers
|
May 4, 2026
Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma
Patrick J Stiff, Cheryl M Czerlanis, Ronald K Potkul, et al.
Gynecologic Oncology
|
July 21, 2004
Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study
Patrick J Stiff, Elizabeth J Shpall, P Y Liu, et al.
Blood
|
April 18, 2009
c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors
Yinshi Guo, Chao Niu, Peter Breslin, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 7, 2012
Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens
Patrick J Stiff, Mary P Fox-Geiman, Karen Kiley, et al.
American Journal of Hematology
|
August 3, 2013
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34(+) hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma
Ivana N Micallef, Patrick J Stiff, Edward A Stadtmauer, et al.
Transplantation and Cellular Therapy
|
April 20, 2026
QTc Prolongation in Allogeneic Hematopoietic Stem Cell Transplantation: Assessing Cardiac Complications and Survival Outcomes
Mark F deBettencourt, Timothy E O'Connor, Kayeromi Gomez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2002
Autologous stem cell transplantation for small cell lung cancer
J Douglas Rizzo, Anthony D Elias, Patrick J Stiff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 4, 2010
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma
Patrick J Stiff, Ivana Micallef, Auayporn P Nademanee, et al.
Transplantation and Cellular Therapy
|
April 9, 2025
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program
Mitchell E Horwitz, Gary J Schiller, Stephanie B Tsai, et al.
Blood
|
February 8, 2008
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)
John A Thompson, Richard I Fisher, Michael Leblanc, et al.
Cancers
|
May 4, 2026
Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma
Patrick J Stiff, Cheryl M Czerlanis, Ronald K Potkul, et al.
Gynecologic Oncology
|
July 21, 2004
Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study
Patrick J Stiff, Elizabeth J Shpall, P Y Liu, et al.
Blood
|
April 18, 2009
c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors
Yinshi Guo, Chao Niu, Peter Breslin, et al.
Page
of 8